Kangstem Biotech's IPO

Kangstem Biotech raised a round of funding on December 01, 2015. Investors include Public.

Kangstem Biotech (강스템바이오텍) (KOSDAQ: 217730) is a global pharmaceutical company focused on cord blood-derived stem cell therapy, cord blood-derived stem cell conditioned media, and stem c…

Articles about Kangstem Biotech's IPO: